£1.3m funding secured to expand clinical research at Sussex hospitals

Hospitals across Sussex are set to benefit from more than one-point-three million pounds in government funding.

The investment will improve clinical research facilities at sites including the Royal Sussex in Brighton, Princess Royal in Haywards Heath and Worthing Hospital.

It’s expected to expand access to trials and enable more advanced studies across the region.

Having improved dedicated research space will enable more crucial research and treatment options to be offered to local people across our hospitals. 

The mainstay of the investment will enable the Trust to relocate and enhance its main research facility at the Royal Sussex County Hospital in Brighton. The new facility, in the hospital's Louisa Martindale Building, will provide 180m² of patient-facing space for research participation close to key acute services, including the Emergency Department, critical care and new Cancer Centre when this opens. This will allow researchers to deliver larger and more complex trials, including early phase and first-in-human studies, which require closer clinical monitoring. 

Alongside the central research facility in Brighton, the funding will support the development of research bases at Princess Royal Hospital and Worthing Hospital. These sites will help bring research opportunities closer to local communities, allowing more patients across Sussex to take part in clinical trials without needing to travel long distances. 

The research base at Princess Royal Hospital will also support the delivery of specialist research including mental and dementia studies as part of our NIHR Commercial Research Delivery Centre (CRDC) Sussex, in partnership with Sussex Partnership NHS Foundation Trust. 

Professor Martin Llewelyn, Clinical Director of Research and Innovation at University Hospitals Sussex and Director of the NIHR CRDC Sussex, said: 

“We are delighted to receive this funding from the NIHR, which will help us strengthen and expand clinical research across Sussex. Research is central to our ambition to deliver excellent care everywhere, improving care and treatment options for our patients, helping our staff develop new skills and expertise, and ensuring people across Sussex benefit from the latest advances in medicine. This investment is strategically important for University Hospitals Sussex because it will strengthen our research infrastructure and help us grow both our research portfolio and our partnerships with life sciences organisations via our NIHR CRDC Sussex – enhancing access to ground-breaking research through our hospitals and across community settings.   

“By expanding and relocating our research facilities, particularly in Brighton where the new facility will sit close to emergency and specialist services, we will be better placed to deliver more advanced studies including early phase clinical trials. At the same time, developing research bases in Haywards Heath and Worthing will help widen access to research across Sussex, ensuring more patients and communities have the opportunity to take part in studies that could shape the future of healthcare.” 

This funding forms part of a £47.8 million national investment from the National Institute for Health and Care Research (NIHR), which is supporting 51 NHS trusts and 79 primary care organisations across England to strengthen their ability to deliver high-quality commercial research. 

Commenting on the national investment, Dr Janet Valentine, Executive Director of Innovation and Research Policy at the Association of the British Pharmaceutical Industry, said: 

“Access to the right equipment across the NHS is essential to ensure that industry-sponsored clinical trials can run efficiently and that more patients have the opportunity to take part in studies of the latest treatments. This welcome new investment through the NIHR and the pharmaceutical industry’s VPAG Investment Programme will help address equipment shortages that can create bottlenecks in hospital-based research. 

 “Funding for research equipment in primary care will also expand the ability of GP practices and community providers to offer research opportunities closer to where people live. Importantly, investment in mobile research units will help extend the reach of clinical trials into underserved communities, ensuring more people can benefit from taking part in research.” 

Get the latest BREAKING NEWS for the SOUTH on your phone by downloading the V2 RADIO APP today!

V2VOUCHERS.CO.UK is offering half-price deals on a wide range of experiences across the South, from meals out at local restaurants to tickets for some of the region’s biggest events.